Skip to main content

Table 2b References to the MSAC and Duration of Assessment

From: The Australian experiment: the use of evidence based medicine for the reimbursement of surgical and diagnostic procedures (1998–2004)

Ref No.

Description

First MSAC Meeting

MSAC Meeting – Endorsed

Minister Sign Off

Duration in Months

MSAC Outcome

1

Prostate cancer screening

    

Unknown

2

Positron emission tomography (PET)

Aug'99

   

Interim

3

Assisted reproductive technology (ART)

    

Unknown

4

Nuchal translucency measurement in the first trimester of pregnancy for screening of trisomy 21 and other autosomal trisomies

Aug'99

 

Oct'02

38

Negative

5

Provision of pulmonary thromboendarectomy (PTE)

Aug'99

Feb'01

Mar'01

19

Positive

6a & 6b

Intracytoplasmic sperm injection (ICSI) using ejaculated sperm

Nov'00

Mar'05

 

52+

Positive

7a

Magnetic Resonance Cholangiopancreatography

    

Positive

7b

Magnetic resonance imaging – (b) Staging of endometrial and cervical carcinoma

Nov'00

Nov'01

Feb'02

15

Positive

8

Intra-operative transoesophageal echocardiography

Nov'00

 

Jun'02

19

Interim

9a(i)

Polymerase chain reaction (PCR) in the diagnosis and monitoring of chronic myeloid leukemia (CML)

Nov'00

Mar'03

Jun'04

43

Positive

9a (ii)

Polymerase chain reaction (PCR) in the diagnosis and monitoring of acute promyelocytic leukemia (APL)

Nov'00

Mar'03

Aug'03

33

Positive

9a (iii)

Polymerase chain reaction (PCR) testing in the diagnosis and monitoring of acut myeloid leukaemia (AML)

Nov'00

Aug'03

Sept'03

34

Positive

9a(iv)

Polymerase chain reaction in the diagnosis and monitoring of patients with BCR-ABL gene rearrangement in acute lymphoid leukaemia

Nov'00

Mar'04

Jun'04

43

Positive

9b

Antenatal Screening for Heritable Thrombophilia (Assessment Report – August 2002)

Nov'00

Aug'02

Oct'02

23

Negative

10 part 2 (i)

Positron Emission Tomography (PET) – additional indications

Nov'00

May'01

Jun'01

7

Positive

10 part 2 (ii)

Positron Emission Tomography (PET) – additional indications

Nov'00

May'01

 

6+

Interim

11a

Off-Pump Coronary Artery Bypass (OPCAB) with the aid of Tissue Stabiliser

Nov'00

Mar'02

May'02

18

Positive

11b

Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) with the aid of Tissue Stabiliser

Nov'00

Mar'02

May'02

18

Positive

12a

Liquid based cytology for cervical screening

Aug'01

Aug'02

Oct'02

14

Negative

12b

Human papillomavirus testing in women with cytological prediction of low-grade abnormality

Aug'01

Aug'02

Oct'02

14

Negative

12c

Computer-assisted image analysis for cervical screening

Aug'01

May'03

Aug'03

24

Negative

12d

Human papillomavirus testing for cervical screening

Aug'01

May'03

Aug'03

24

Negative

12e

The use of human papillomavirus (HPV) testing to monitor effectiveness of treatment of high-grade intraepithelial abnormalities of the cervix

Aug'01

Mar'04

 

31+

Positive

13

Multifocal Multichannel Objective Perimetry

Nov'01

Nov'02

Dec'02

13

Negative

14

Laparascopic adjustable gastric banding for morbid obesity

Mar'02

Aug'03

Sept'03

18

Positive

15

Transanal Endoscopic Microsurgery

May'02

Mar'03

 

10

Positive

16

Positron Emission Tomography (PET)

Aug'02

Nov'03

Mar'05

31

Positive

17

Neonatal Hearing Screening

Aug'02

Mar'04

Mar'05

31

Unknown

18

Faecal Occult Blood Test

Aug'02

May'03

  

Partial

19

Bone Densitometry

Aug'02

Nov'04

 

27+

Withdrawn

20

Carotid Stenting

Mar'03

Mar'05

Jul'05

28

Partial

21

Drug (Sirolimus) eluting Stents – Report not published – Subsumed by Ref. 30

Mar'03

Aug'03

  

Ref 30

22

Treatment of hyperhidrosis of the axillae

Nov'03

   

Withdrawn

23

Injection of Botulinum Toxin for the treatment of spasticity following stroke

    

Withdrawn

24

Injection of Botulinum Toxin for the treatment of focal spasticity in adults

    

Withdrawn

25

Magnetic resonance cholangiopancreatograpy (MRCP)

Nov'03

Mar'05

Jul'05

20

Positive

26

Positron emission tomography (PET) for epilepsy

Nov'03

Nov'04

Mar'05

18

Positive

27

Vertebroplasty

Mar'04

  

12

Interim

28

Laparoscopic removal of malignancies

Mar'04

   

Withdrawn

29

Artificial intervertebral disc replacement – Application 1090

Mar'04

Nov'05

 

21+

App 1090

30

Drug eluting stents

Mar'04

Nov'04

Mar'05

12

Noted

31

Endometrial ablation for chronic ractory menorrhagia

Mar'04

Mar'05

Jul'05

16

Unchanged

32

Implantable Cardiac Defibrillators for Chronic Heart Failure

Nov'04

  

13+

Incomplete

33

Treatment of cerebral aneurysms

Nov'04

  

13+

Incomplete

  1. Source: MSAC Web Site: http://www7.health.gov.au/msac/ – Accessed 6thJan'06